Exelixis (EXEL) Tops Q4 EPS by 16c, provides guidance
Exelixis (NASDAQ: EXEL) reported Q4 EPS of $0.55, $0.16 better than the analyst estimate of $0.39. Revenue for the quarter came in at $566.8 million versus the consensus estimate of $559.89 million.
GUIDANCE:
Exelixis sees FY2025 revenue of $2.15-2.25 billion, versus the consensus of $2.251 billion.
For earnings history and earnings-related data on Exelixis (EXEL) click here.
